Logicboots introduced Coeur.AI at VivaTech Paris 2026. This launch is part of Logicboots' strategy to expand its global footprint through startup accelerators.
Why It Matters
A new AI product, Coeur.AI, launched at a major European tech event like VivaTech. For CROs and generic pharma, this means evaluating new solutions is a constant. With the August 2026 EU AI Act enforcement approaching, due diligence on these tools is not optional. You must understand their data handling and risk profiles before considering adoption.
What To Do About It
Before engaging with any new AI vendor, conduct an internal audit of your sensitive data flows. Map out what data leaves your premises or private cloud. This prepares you to ask the right questions about data sovereignty and compliance, crucial for pharma operations.
Sources
Related Signals
Nature published a cautionary tale about RAG in clinical practice.
4 Jul 2026
Mankind Pharma partnered with Denovo Sciences for AI-led drug discovery.
2 Jul 2026
Galux is pushing AI protein design, aiming for bigger global pharma deals by BIO USA 2026. This indicates a clear industry focus on advanced AI applications for drug discovery and development.
29 Jun 2026